Clinical outcome of treatment with pemetrexed/cisplatin in patients with EGFR-mutation negative (EGFR-) metastatic non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Storozhakova, Anna E. [1 ]
Vladimirova, Liubov Yu [1 ]
Kit, Oleg Ivanovich [1 ]
机构：
[1] Rostov Sci Res Inst Oncol, Rostov Na Donu, Russia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19047
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Clinical outcome of treatment of metastatic non-small cell lung cancer in patients harboring uncommon EGFR mutation
    Chantharasamee, J.
    Poungvarin, N.
    Danchaivijitr, P.
    Techawatanawanna, S.
    [J]. BMC CANCER, 2019, 19 (1)
  • [2] Clinical outcome of treatment of metastatic non-small cell lung cancer in patients harboring uncommon EGFR mutation
    J. Chantharasamee
    N. Poungvarin
    P. Danchaivijitr
    S. Techawatanawanna
    [J]. BMC Cancer, 19
  • [3] COST-EFFECTIVENESS OF AFATINIB, ERLOTINIB, AND CISPLATIN/PEMETREXED FOR FIRST-LINE TREATMENT OF METASTATIC EGFR-MUTATION POSITIVE NON-SMALL CELL LUNG CANCER
    Ting, J.
    Ho, T.
    Xiang, P.
    Abdel-Sattar, M.
    Sugay, A.
    Wilson, L. S.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A84 - A84
  • [4] Clinical Outcome and Toxicity Profiles of Patients with EGFR-mutation Positive Non-Small-Cell Lung Cancer
    Munawar, K.
    Sheikh, H.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S621 - S622
  • [5] EGFR mutation in non-small cell lung cancer(NSCLC) in South Croatia
    Mladinov, Suzana
    Skopljanac, Ivan
    Ivcevic, Veljka
    Kuret, Sendi
    Durdov, Meri Glavina
    Mise, Kornelija
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [6] EGFR-mutation analysis, treatment and outcomes in newly diagnosed patients with non-small cell lung cancer (NSCLC): a single-institution retrospective review
    Enting, D.
    Januszewski, A.
    Benepal, T.
    [J]. LUNG CANCER, 2012, 75 : S5 - S5
  • [7] Treatment outcome of non-small cell lung cancer (NSCLC)-prognostic value of EGFR protein
    El-Metnawi, W
    AbdelSalam, M
    El-Nahas, T
    [J]. LUNG CANCER, 2005, 49 : S169 - S169
  • [8] Catechol estrogen profiles of patients with EGFR- and ALK-positive non-small cell lung cancer (NSCLC)
    Bodor, J. Nicholas
    Treat, Joseph
    Krzizike, Daniel D.
    Zawislak, Carolyn L.
    Vanderveer, Lisa
    Eidbo, Sarah
    Ross, Eric A.
    Edelman, Martin J.
    Andrews, Andrew J.
    Clapper, Margie L.
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [9] LONG-TERM OUTCOME OF INTRATHECAL CHEMOTHERAPY WITH PEMETREXED IN LEPTOMENINGEAL METASTASIS FROM NON-SMALL CELL LUNG CANCER WITH EGFR-MUTATION: A CASE REPORT
    Wang, Hui
    Zhou, Jiangfen
    Wen, Lei
    Hong, Weiping
    Cai, Linbo
    [J]. NEURO-ONCOLOGY, 2021, 23 : 75 - 75
  • [10] The Clinical and Economic Impact of Inaccurate EGFR Mutation Tests in the Treatment of Metastatic Non-Small Cell Lung Cancer
    Cheng, Mindy M.
    Palma, John F.
    Scudder, Sidney
    Poulios, Nick
    Liesenfeld, Oliver
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2017, 7 (03):
12345